Literature DB >> 16828235

Paratuberculosis and Type I diabetes: is this the trigger?

C Thomas Dow1.   

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease. The etiology of T1DM is incompletely understood but environmental agent(s) are thought to trigger T1DM in the genetically at risk. Exposure to cow's milk early in life is a recognized risk factor in the development of T1DM. Mycobacterium avium ss. paratuberculosis (MAP) is the cause of bovine Johne's disease and also is thought to act as an immune antigen in Crohn's disease and other granulomatous diseases. MAP is shed in cow's milk and has been shown to survive pasteurization. Genetic susceptibilities, epitope homologies and epidemiologic studies are presented that support MAP as a causative agent of T1DM in the genetically at risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828235     DOI: 10.1016/j.mehy.2006.04.029

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  16 in total

1.  Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis.

Authors:  J Todd Kuenstner; William Chamberlin; Saleh A Naser; Michael T Collins; Coad Thomas Dow; John M Aitken; Stuart Weg; Grzegorz Telega; Kuruvilla John; David Haas; Torsten M Eckstein; Maher Kali; Christine Welch; Thomas Petrie
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

2.  Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitus.

Authors:  Temitope C Ekundayo; Ayodeji O Falade; Bright E Igere; Chidozie D Iwu; Mary A Adewoyin; Tosin A Olasehinde; Oluwatosin A Ijabadeniyi
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

3.  Detection of Mycobacterium avium ss. Paratuberculosis in Blau Syndrome Tissues.

Authors:  C Thomas Dow; Jay L E Ellingson
Journal:  Autoimmune Dis       Date:  2010-06-20

4.  Mycobacterium avium subsp. paratuberculosis as a trigger of type-1 diabetes: destination Sardinia, or beyond?

Authors:  Pittu Sandhya Rani; Leonardo A Sechi; Niyaz Ahmed
Journal:  Gut Pathog       Date:  2010-03-29       Impact factor: 4.181

5.  Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis.

Authors:  Leonardo A Sechi; Valentina Rosu; Adolfo Pacifico; Giovanni Fadda; Niyaz Ahmed; Stefania Zanetti
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

6.  M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.

Authors:  Coad Thomas Dow
Journal:  Autoimmune Dis       Date:  2012-09-29

7.  Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus.

Authors:  Daniela Paccagnini; Lee Sieswerda; Valentina Rosu; Speranza Masala; Adolfo Pacifico; Maria Gazouli; John Ikonomopoulos; Niyaz Ahmed; Stefania Zanetti; Leonardo A Sechi
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

8.  Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus.

Authors:  Valentina Rosu; Niyaz Ahmed; Daniela Paccagnini; Gerald Gerlach; Giovanni Fadda; Seyed E Hasnain; Stefania Zanetti; Leonardo A Sechi
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

9.  Exploring the role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of type 1 diabetes mellitus: a pilot study.

Authors:  Saleh A Naser; Saisathya Thanigachalam; C Thomas Dow; Michael T Collins
Journal:  Gut Pathog       Date:  2013-06-13       Impact factor: 4.181

10.  Mycobacterium avium subspecies paratuberculosis is not associated with type-2 diabetes mellitus.

Authors:  Valentina Rosu; Niyaz Ahmed; Daniela Paccagnini; Adolfo Pacifico; Stefania Zanetti; Leonardo A Sechi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-04-22       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.